AMANDA BROOKS: Open Payments
NPI 1427674472 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 55 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $299 · 2025 $1,131
Food & beverage: $956Education: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $273 |
| Travere Therapeutics, Inc. | 9 | $206 |
| OPKO Pharmaceuticals, LLC | 12 | $172 |
| Novartis Pharmaceuticals Corporation | 7 | $158 |
| Mallinckrodt Hospital Products Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Calliditas Therapeutics US Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| SCPHARMACEUTICALS INC. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: KRYSTEXXA, RAYALDEE, ACTHAR, JYNARQUE, TARPEYO, Kerendia, FUROSCIX, FARXIGA.
Industry payments across FL — which companies pay providers there.
